Human Genome Informatics: Coming of Age

Author(s):  
Christophe G. Lambert ◽  
Darrol J. Baker ◽  
George P. Patrinos
2019 ◽  
Vol 70 (1) ◽  
pp. 307-321 ◽  
Author(s):  
C. Frank Bennett

The first published description of therapeutic applications of antisense oligonucleotide (ASO) technology occurred in the late 1970s and was followed by the founding of commercial companies focused on developing antisense therapeutics in the late 1980s. Since the late 1980s, there has been steady progress in improving the technology platform, taking advantage of advances in oligonucleotide chemistry and formulations as well as increased understanding of the distribution and safety of ASOs. There are several approved ASO drugs and a broad pipeline in development. In addition, advances in understanding human disease, including the genetic basis for most monogenic diseases and the availability of the full human genome sequence, have created numerous therapeutic applications for the technology. I summarize the state of the technology and highlight how advances in the technology position ASOs to be an important contributor to future medicines.


2020 ◽  
Vol 146 (5) ◽  
pp. 997-1001
Author(s):  
Deborah L. Stone ◽  
David B. Beck ◽  
Kalpana Manthiram ◽  
Yong Hwan Park ◽  
Jae Jin Chae ◽  
...  

2019 ◽  
Vol 63 (6) ◽  
pp. 757-771 ◽  
Author(s):  
Claire Francastel ◽  
Frédérique Magdinier

Abstract Despite the tremendous progress made in recent years in assembling the human genome, tandemly repeated DNA elements remain poorly characterized. These sequences account for the vast majority of methylated sites in the human genome and their methylated state is necessary for this repetitive DNA to function properly and to maintain genome integrity. Furthermore, recent advances highlight the emerging role of these sequences in regulating the functions of the human genome and its variability during evolution, among individuals, or in disease susceptibility. In addition, a number of inherited rare diseases are directly linked to the alteration of some of these repetitive DNA sequences, either through changes in the organization or size of the tandem repeat arrays or through mutations in genes encoding chromatin modifiers involved in the epigenetic regulation of these elements. Although largely overlooked so far in the functional annotation of the human genome, satellite elements play key roles in its architectural and topological organization. This includes functions as boundary elements delimitating functional domains or assembly of repressive nuclear compartments, with local or distal impact on gene expression. Thus, the consideration of satellite repeats organization and their associated epigenetic landmarks, including DNA methylation (DNAme), will become unavoidable in the near future to fully decipher human phenotypes and associated diseases.


1959 ◽  
Vol 24 (2) ◽  
pp. 195-200
Author(s):  
Jon Eisenson
Keyword(s):  

2006 ◽  
Vol 11 (4) ◽  
pp. 324-326 ◽  
Author(s):  
Anja Bregar
Keyword(s):  

1996 ◽  
Vol 41 (9) ◽  
pp. 888-889
Author(s):  
Lisa C. McGuire
Keyword(s):  

2000 ◽  
Vol 45 (3) ◽  
pp. 295-297
Author(s):  
Steven Jones
Keyword(s):  

1995 ◽  
Vol 40 (6) ◽  
pp. 563-564
Author(s):  
Peggy W. Nash
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document